Botulinum neurotoxin type A injections reduce spasticity in mild to moderate hereditary spastic paraplegia – Report of 19 cases: Hecht MJ et al.


Movement Disorders Vol. 23, No. 2, 2008, pp. 228–233
© 2007 Movement Disorder Society


Martin J. Hecht, MD,  
Henning Stolze, MD,  
Matthias Auf dem Brinke, MD,  5
Ralf Giess, MD,  6
Thoams Treig, MD,  7,8
Martin Winterholler, MD,  9
and Joerg Wissel, MD,  10
for the German Spasticity Education Group


Author Details
1   Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany
2   Department of Neurology, BKH Kaufbeuren, Germany
3   Department of Neurology, University of Kiel, Kiel, Germany
4   Department of Neurology, Diako Hospital, Flensburg, Germany
5   Department of Neurological Rehabilitation, Bad Wildungen, Germany
6   Department of Neurology, Henriettenstiftung, Hannover, Germany
7   Neurological Rehabilitation Centre, Ernst-Moritz-Arndt University, Greifswald, Germany
8   Neurological Rehabilitation Centre, Schwarzwaldkliniken, Bad Krozingen, Germany
9   Department of Neurology, Rummelsberger Kliniken, Schwarzenbruck, Germany
10  Department of Neurological Rehabilitation, Beelitz Heilsta¨tten, Beelitz, Germany